Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain
Clinical trial NCT05096494 · COMPLETED
Trial details
- NCT number
- NCT05096494
- Sponsor
- Scilex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-29
- Primary completion
- 2023-05-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.